Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Up 139.2% in August

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 2,000 shares, an increase of 139.2% from the August 15th total of 836 shares. Based on an average trading volume of 54,704 shares, the short-interest ratio is currently 0.0 days.

Revolution Medicines Stock Performance

RVMDW stock traded up $0.15 during midday trading on Monday, hitting $11.44. The company’s stock had a trading volume of 43,945 shares, compared to its average volume of 108,229. Revolution Medicines has a 12 month low of $0.22 and a 12 month high of $13.44. The firm’s 50-day moving average is $10.65 and its 200-day moving average is $6.73.

Revolution Medicines Company Profile

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.